BACE1 and amyloidosis: It remains to be established if a partial reduction of BACE1 levels, possibly before the appearance of amyloid pathology, may prevent these detrimental side effects, maintaining the cleavage of substrates other than Aβ and preserving the physiological functions of the enzyme.